DRUG DISCOVERY PRODUCTS & SERVICES

• Complete Organ-Chip Solutions To Fast-Track Your Drug Discovery

  From cancer models to high-throughput screening, Organ-Chip platforms accelerate development, improve safety, and support regulatory compliance for next-generation therapies.

• Fast And Reliable Real-Time Imaging

  This advanced imaging approach uses spatial and morphological data for more detailed analysis, enabling breakthroughs in understanding cell growth, function, and interaction without usual limitations.

• Advanced Performance And Fluorochrome Flexibility

  Achieve top spectral resolution with advanced optical design, quality control, and workflows. Simplify experiments while meeting your panel and fluorochrome needs for high-dimensional flow cytometry.

• Immunoassays For Cytokine And Chemokine Quantitation

  Achieve precise cytokine and chemokine quantitation with flexible immunoassay solutions, including multiplexed bead-based assays, ELISA kits, and ELISPOT reagents, for human, rat, and mouse studies.

• Minimize Spillover Spread And Improve Panel Resolution

  Unlock cleaner flow cytometry data with engineered fluorochromes that reduce spillover and boost resolution. Design complex panels easily across conventional and spectral systems.

• Expand Your T-Cell Research With Confidence

  Achieve deeper T-cell characterization with a panel designed for flexibility. Streamline multicolor panel design, see higher resolution markers, and enable intracellular cytokine detection together.

• Altasciences' State-Of-The-Art Research Facilities

  12/2/2025

  With over 585,000-sq.-ft. of purpose-built space, our preclinical facilities across North America are designed to support your drug development journey, from early discovery to IND/NDA submission.

• Powering Production Of Viral Vector-Based Therapies

  11/14/2025

  Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.

• Comprehensive Suite Of In Vivo And In Vitro Services

  11/13/2025

  Accelerate vaccine development with integrated services, supporting all common vaccine types from discovery through IND. Leverage expertise in immunogenicity, dose-response, and efficacy studies.

• Centralized Data Aggregation Software

  11/10/2025

  Centralized data aggregation and advanced visualization streamline compliance reporting and batch documentation. Discover a solution that enables rapid integration of diverse equipment and improves efficiency.

• Automated, Single-Use Systems For TFF At Multiple Scales

  11/7/2025

  Platform of automated, single-use systems for tangential flow filtration at multiple scales.

• Xcellerex™ X-Platform Bioreactors: A Next-Generation Single-Use Bioreactor System

  11/6/2025

  Accelerate your gene therapy manufacturing with the Xcellerex™ X-platform – a next-generation single-use bioreactor system designed for viral vector workflows.

• Optimize Your Cell Line Strategy For Better Viral Vector Production

  11/6/2025

  Optimize your cell line strategy for better viral vector production.

• HyClone™ Cell Culture Media For Viral Vector Production

  11/6/2025

  Whether you're looking to boost performance, enhance your capabilities, or simply get consistent, high-quality results, HyClone™ peak expression medium and HyClone™ prime expression medium are the solutions for you.